UroToday (KC) 07-Dec-07

From Kidney Cancer Resource

Jump to: navigation, search

To Go To UroToday (KC)

Elective Nephron Sparing Surgery for Renal Cell Carcinoma Larger Than 4 cm

Elective Nephron Sparing Surgery for Renal Cell Carcinoma Larger Than 4 cm - Abstract

Departments of Urology and Medical Biostatistics, Epidemiology and Informatics (BR), Johannes Gutenberg University, Mainz, Germany

Elective Nephron Sparing surgery is established as an alternative to radical Nephrectomy for renal cell carcinoma if Tumours are small (4 cm or less, stage T1a). We compared outcomes in patients with renal cell carcinoma 4 cm or less (small) vs more than 4 cm (large) who were treated with Nephron Sparing surgery.

Between 1979 and 2006, 618 patients underwent elective Nephron Sparing surgery at our institution. Of these patients 474 (76.7%) had renal cell carcinoma, which was 4 cm or less in 372 (78.5%) and more than 4 cm in 102 (21.5%). Followup was 4.7 (range 0.1 to 23.9) years for small and 4.7 (range 0.1 to 24.1) years for large Tumours. Cancer specific survival and local recurrence free survival were estimated.

The estimated cancer specific survival rate at 5 years was 97.9% and 95.8%, and at 10 years it was 94.9% and 95.8% for small and large Tumours, respectively (log rank p = 0.583). The survival rate free of local recurrence at 5 years was 98.5% and 98.3%, and at 10 years it was 93.9% and 98.3% for small and large Tumours, respectively (log rank p = 0.282). In contrast to Tumour size, stage 3 was associated with a significant higher risk of Tumour related death.

Elective Nephron Sparing surgery is oncologically safe in select patients with localized renal cell carcinoma more than 4 cm. In our series the selection criterion for choosing elective Nephron Sparing surgery rather than radical Nephrectomy over the years has consistently been safe surgical resectability rather than tumor size. However, there is a correlation between Tumour size and unfavorable pathological Tumour characteristics, which prompts caution when choosing elective nephron sparing surgery for all large Tumours.

To view the original of this article Click Here


Convert This Page to PDF format

Disclaimer

Kidney Cancer Resource (KCR) is not influenced by sponsors. The information contained herein is not intended as a substitute for the advice of an appropriately qualified and licensed physician or other licensed health care provider. The information provided here is for educational and information purposes only. Early accurate Diagnosis (Dx.) saves lives. Please check with a physician if you suspect you are ill, never ignore Symptoms. To help your health care specialist make an accurate Diagnosis please keep notes of dates, times and details of your Symptoms. We are not offering medical advice nor do we consider links, individuals or articles accessed through this site to be offering medical advice.

E&OE - Errors & Omissions Excepted

As much of the information posted on this Web Site for peoples convenience is of a medical or technical nature, and may be a matter of life or death the E&OE is a Disclaimer showing that to the best of our ability information is accurate and correctly written or transcribed. Before acting on information on this site you are responsible for checking it with your relevant medical team. We can not be held responsible for any Errors & Omissions made; nor for information on links and articles provided in good faith.

Personal tools
Locations of visitors to this page